152 related articles for article (PubMed ID: 7282676)
1. Reducing the number of formulary theophylline preparations.
Anandan JV
Am J Hosp Pharm; 1981 Apr; 38(4):511-3. PubMed ID: 7282676
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of an enteral products formulary.
Durfee DD; Skinner-Domet VM
Am J Hosp Pharm; 1984 Nov; 41(11):2352-4. PubMed ID: 6439034
[TBL] [Abstract][Full Text] [Related]
3. Formulary management to reduce cost: P & T committee strategies.
Roberts MJ; Summerfield MR
Hosp Formul; 1986 Apr; 21(4):481-3, 488-92. PubMed ID: 10276289
[TBL] [Abstract][Full Text] [Related]
4. Evaluating a restrictive formulary system by assessing nonformulary-drug requests.
Green JA; Chawla AK; Fong PA
Am J Hosp Pharm; 1985 Jul; 42(7):1537-41. PubMed ID: 4025350
[TBL] [Abstract][Full Text] [Related]
5. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
Cramer R; Wright C
Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
[TBL] [Abstract][Full Text] [Related]
6. P & T Committee interview: strategies to ensure an effective formulary system.
Riff L; Hutchinson R
Hosp Formul; 1988 Nov; 23(11):901-4, 907-8. PubMed ID: 10290754
[TBL] [Abstract][Full Text] [Related]
7. Controlling financial variables--changing prescribing patterns.
Abramowitz PW
Am J Hosp Pharm; 1984 Mar; 41(3):503-15. PubMed ID: 6367444
[TBL] [Abstract][Full Text] [Related]
8. Financial impact of formulary revision of second-generation cephalosporins.
Andrews JD; Hafting S
Can J Hosp Pharm; 1988 Jun; 41(3):125-7. PubMed ID: 10288499
[TBL] [Abstract][Full Text] [Related]
9. Total formulary review--the easy way.
Chase K; Meyer JD; Kelly WN
Hosp Pharm; 1984 Mar; 19(3):159-62. PubMed ID: 10265845
[TBL] [Abstract][Full Text] [Related]
10. Formulary evaluation of third-generation cephalosporins using decision analysis.
Cano SB; Fujita NK
Am J Hosp Pharm; 1988 Mar; 45(3):566-9. PubMed ID: 3285673
[TBL] [Abstract][Full Text] [Related]
11. Achieving parenteral nutrition cost savings through prescribing guidelines and formulary restrictions.
Maswoswe JJ; Newcomer DR; Quandt CM
Am J Hosp Pharm; 1987 Jun; 44(6):1376-81. PubMed ID: 3113237
[TBL] [Abstract][Full Text] [Related]
12. P & T Committee perspectives: maintaining a successful formulary system in a private community hospital.
Benner EJ; Mykita L; Brown K
Hosp Formul; 1990 Apr; 25(4):423-6, 428, 430. PubMed ID: 10104233
[TBL] [Abstract][Full Text] [Related]
13. Application of decision analysis to drug selection for formulary addition.
Kresel JJ; Hutchings HC; MacKay DN; Weinstein MC; Read JL; Taylor-Halvorsen K; Ashley H
Hosp Formul; 1987 Jul; 22(7):658-63, 673, 676. PubMed ID: 10282682
[TBL] [Abstract][Full Text] [Related]
14. Developing a unit-of-use drug distribution system for the hospital emergency room.
Schiavone JD
Hosp Pharm; 1981 Apr; 16(4):208-9, 214-5, 219 passim. PubMed ID: 10251101
[TBL] [Abstract][Full Text] [Related]
15. Criteria-based DUE aids in selection of preferred agent.
Drea EJ
Hosp Formul; 1991 Nov; 26 Suppl D():25-7. PubMed ID: 10136562
[TBL] [Abstract][Full Text] [Related]
16. P & T Committee role in advocating rational therapeutics.
Borreson R
Hosp Formul; 1986 May; 21(5):590-8. PubMed ID: 10311625
[TBL] [Abstract][Full Text] [Related]
17. P&T Committee guidelines for antibiotic cost comparisons.
McCue JD
Hosp Formul; 1986 Jun; 21(6):703-6. PubMed ID: 10276798
[TBL] [Abstract][Full Text] [Related]
18. Use of ampicillin-sulbactam before and after formulary inclusion.
Koch KE; Taylor MR
Am J Hosp Pharm; 1991 Jul; 48(7):1492-6. PubMed ID: 1882880
[TBL] [Abstract][Full Text] [Related]
19. Strategies for deleting popular drugs from a hospital formulary.
Lemay AP; Salzer LB; Visconti JA; Latiolais CJ
Am J Hosp Pharm; 1981 Apr; 38(4):506-10. PubMed ID: 7282675
[TBL] [Abstract][Full Text] [Related]
20. Prospective reimbursement and DRGs: implications for formulary management.
Enright SM
Hosp Formul; 1983 Oct; 18(10):989-90, 999-1000. PubMed ID: 10310246
[No Abstract] [Full Text] [Related]
[Next] [New Search]
